Figure 1.
Selection process for untreated advanced lung adenocarcinoma with ALK rearrangement and/or EGFR mutation and HRCT image. ALK, anaplastic lymphoma kinase; EGFR, epidermal growth factor receptor; HRVT, high-resolution computed tomography.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.